research
Ukraine's clinical trials still recruiting despite ongoing war
October 12 by Leila HawkinsClinical research in Ukraine is showing signs of recovery more than seven months since war began
How AI is making drug discovery safer and faster
June 24 by Leila HawkinsWe find out how Sanofi is using AI to predict the toxicity of drugs earlier in the discovery phase
How phenotyping could transform the way obesity is treated
June 23 by Leila HawkinsPharma IQ speaks to Phenomix about using genetics to better understand the causes of obesity
CRISPR therapy could offer one-time cure for sickle cell disease
June 20 by Leila HawkinsCRISPR therapy shows promise as a cure for severe sickle cell disease
Longevity research is on the rise with Genflow latest to file for patent
June 10 by Leila HawkinsGenflow has filed a patent application for anti-aging therapies
Top 10 largest clinical research organizations
May 20 by Pharma IQPharma IQ’s guide to the world’s top 10 contract research organizations in pharma and biotech
The latest in cancer treatments: Recreating the tumor environment
April 28 by Leila HawkinsPharma IQ speaks to HCS Pharma about creating the technology that reproduces tumor microenvironments to treat cancer
AstraZeneca shares positive results for its drug to lower cholesterol
April 13 by Leila HawkinsPharma IQ speaks to AstraZeneca about its promising new drug candidate to tackle one of the world’s leading causes of death
Why R&D must digitalize and become data-centric
April 08 by Leila HawkinsFind out why digital transformation and the cloud are essential tools for R&D companies today in this report by Pharma IQ produced with Benchling
Sanofi announces partnership to develop new class of oncology therapeutics
March 30 by Leila HawkinsPharma IQ speaks to IGM Biosciences and Sanofi about their new collaboration
An introduction to nanomedicine with the World Nano Foundation
March 25 by Leila HawkinsPharma IQ speaks to the World Nano Foundation about finding treatments for disease on the nanoscopic scale
The consequences of Russia’s war for drug development
March 03 by Leila HawkinsEight days into the conflict, Pharma IQ looks at the impact the conflict is having on pharma and how the industry has been responding